Found 22 results
Author Title [ Type(Desc)] Year
Filters: Author is Belshe, RB  [Clear All Filters]
Journal Article
B. S. Graham, McElrath, M. J., Connor, R. I., Schwartz, D. H., Gorse, G. J., Keefer, M. C., Mulligan, M. J., Matthews, T. J., Wolinsky, S. M., Montefiori, D. C., Vermund, S. H., Lambert, J. S., Corey, L., Belshe, R. B., Dolin, R., Wright, P. F., Korber, B. T., Wolff, M. C., and Fast, P., Analysis of Intercurrent Human Immunodeficiency Virus Type 1 Infections in Phase I and II Trials of Candidate AIDS Vaccines, J Infec Dis, vol. 177, pp. 310-319, 1998.
J. C. King, Treanor, J., Fast, P. E., Wolff, M. C., Yan, L., Iacuzio, D., Readmond, B., O’Brien, D., Mallon, K., Highsmith, W. E., Lambert, J. S., and Belshe, R. B., Comparison of the safety, vaccine virus shedding and immunogenicity of influenza virus vaccine, trivalent, types A and B, live-cold-adapted (LAIV) administered to HIV-infected and non-HIV-infected adults, J Infec Dis, vol. 181, pp. 725-8, 2000.
R. B. Belshe, Heineman, T. C., Bernstein, D. I., Bellamy, A. R., Ewell, M., van der Most, R., and Deal, C. D., Correlate of Immune Protection Against HSV-1 Genital Disease in Vaccinated Women, J Infect Dis, vol. 209, pp. 828-836, 2014.
B. R. Luce, Zangwill, K. M., Palmer, C. S., Mendelman, P., Yan, L., Wolff, M. C., Cho, I., Marcy, M., Iacuzio, D., and Belshe, R. B., Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children, Pediatrics, vol. 108, p. E24, 2001.
S. Sabbaj, Mulligan, M. J., Hsieh, R. H., Belshe, R. B., and , Cytokine profiles in seronegative volunteers immunized with a recombinant canarypox and gp120 prime-boost HIV-1 vaccine. NIAID AIDS Vaccine Evaluation Group, AIDS Res HumRetroviruses, vol. 14, pp. 1365-74, 2000.
R. B. Belshe, Newman, F. K., Frey, S. E., Couch, R. B., Treanor, J. J., Tacket, C. O., and Yan, L., Dose-dependent neutralizing-antibody responses to vaccinia, Journal of Infectious Diseases, vol. 189, pp. 493-7, 2004.
R. B. Belshe, Mendelman, P. M., Treanor, J., King, J., Gruber, W., Piedra, P., Bernstein, D. I., Hayden, F. G., Kotloff, K., Zangwill, K., Iacuzio, I., and Wolff, M. C., The efficacy of live attenuated, cold adapted, trivalent, intranasal, influenza virus vaccine in children, N Engl J Med, vol. 338, pp. 1405-12, 1998.
R. B. Belshe, Gruber, W., Mendelman, P. M., Cho, I., Reisinger, K., Block, S., Wittes, J., Iacuzio, D., Piedra, P., Treanor, J., King, J., Kotloff, K., Bernstein, D. I., Hayden, F. G., Zangwill, K., Yan, L., and Wolff, M. C., Efficacy of Vaccination with Live Attenuated, Cold-Adapted, Trivalent, Intranasal Influenza Virus Vaccine Against a Variant (A/Sidney) not Contained in the Vaccine, J Pediatric, vol. 136, pp. 168-175, 2000.
R. B. Belshe, Leone, P. A., Bernstein, D. I., Wald, A., Levin, M., Stapleton, J. T., Gorfinkel, I., Morrow, R. L., Ewell, M. G., Stokes-Riner, A., Dubin, G., Heineman, T. C., Schulte, J. M., and Deal, C. D., Efficacy Results of A Trial of A Herpes Simplex Vaccine, N Engl J Med, vol. 366, no. 1, pp. 34-43, 2012.
D. I. Bernstein, Bellamy, A. R., Hook, E. W. 3rd, Levin, M. J., Wald, A., Ewell, M. G., Wolff, P. A., Deal, C. D., Heineman, T. C., Dubin, G., and Belshe, R. B., Epidemiology, Clinical Presentation, and Antibody Response to Primary Infection With Herpes Simplex Virus Type 1 and Type 2 in Young Women, Clin Infect Dis, vol. 56, pp. 344-351, 2013.
I. M. Longini, Halloran, M. E., Nizam, A., Wolff, M. C., Mendelman, P. M., Fast, P. E., and Belshe, R. B., Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic control, Vaccine, vol. 18, pp. 1902-9, 2000.
G. J. Gorse, Corey, L., Patel, G. B., Mandava, M., Hsieh, R. H., Matthews, T. J., Walker, M. C., McElrath, M. J., Berman, P. W., Eibl, M. M., and Belshe, R. B., HIV-1MN recombinant glycoprotein 160 vaccine-induced cellular and humoral immunity boosted by HIV-1MN recombinant glycoprotein 120 vaccine, AIDS Res HumRetroviruses, vol. 15, pp. 115-32, 1999.
J. M. Schulte, Bellamy, A. R., Hook, E. W., Bernstein, D. I., Levin, M. J., Leone, P. A., Sokol-Anderson, M., Ewell, M., Wolff, P. A., Heineman, T. C., and Belshe, R. B., HSV-1 and HSV-2 Seroprevalence in the United States Among Asymptomatic Women Unaware of any Herpes Simplex Virus Infection (Herpevac Trial for Women), Southern Medical Journal, vol. 107, pp. 79-84, 2014.
R. B. Belshe, Frey, S. E., Graham, I. L., Anderson, E. L., Jackson, L. A., Spearman, P., Edupuganti, S., Mulligan, M. J., Rouphael, N., Winokur, P., Dolor, R. J., Woods, C. W., Walter, E. B., Chen, W. H., Turley, C., Edwards, K. M., Creech, C. B., Hill, H., and Bellamy, A. R., Immunogenicity of Avian Influenza A/Anhui/01/2005(H5N1) Vaccine with MF59 Adjuvant: A Randomized Clinical Trial, JAMA, vol. 312, pp. 1420-1428, 2014.
J. S. Kennedy, Frey, S. E., Yan, L., Rothman, A. L., Cruz, J., Newman, F. K., Orphin, L., Belshe, R. B., and Ennis, F. A., Induction of Human T-Cell-Mediated Immune Responses After Primary and Secondary Smallpox Vaccination, J Infect Dis, vol. 190, no. 7, pp. 1286-1294, 2004.
S. Sabbaj, Mulligan, M. J., Hsieh, R. H., Belshe, R. B., and , NIAID AIDS Vaccine Evaluation Group. Cytokine profiles in seronegative volunteers immunized with a recombinant canarypox and gp 120 prime-boost HIV-1 vaccine, AIDS Res HumRetroviruses, vol. 14, pp. 1365-74, 2000.
S. E. Frey, Winokur, P. L., Hill, H., Goll, J. B., Chaplin, P., and Belshe, R. B., Phase II Randomized, Double-Blinded Comparison of a Single High Dose (5×10(8) TCID 50) of Modified Vaccinia Ankara Compared to a Standard Dose (1×10(8) TCID50) in Healthy Vaccinia-Naïve Individuals, Vaccine, vol. 32, pp. 2732-2739, 2014.
S. E. Frey, Bernstein, D. I., Brady, R. C., Keitel, W. A., Sahly, H. E., Rouphael, N. G., Mulligan, M. J., Atmar, R. L., Edupuganti, S., Patel, S. M., Dickey, M., Graham, I., Anderson, E. L., Noah, D. L., Hill, H., Wolff, M., and Belshe, R. B., Phase II Trial in Adults of Concurrent or Sequential 2009 Pandemic H1N1 and 2009-2010 Seasonal Trivalent Influenza Vaccinations, Vaccine, vol. 33, pp. 163-173, 2015.
D. F. Hoft, Lottenbach, K., Goll, J. B., Hill, H., Winokur, P. L., Patel, S. M., Brady, R. C., Chen, W. H., Edwards, K., Creech, C. B., Frey, S. E., Blevins, T. P., Salomon, R., and Belshe, R. B., Priming Vaccination with Influenza Virus H5 Hemagglutinin Antigen Significantly Increases the Duration of T cell Responses Induced by a Heterologous H5 Booster Vaccination, J Infect Dis, vol. 214, no. 7, pp. 1020-1029, 2016.
S. E. Frey, Bernstein, D. I., Gerber, M. A., Keyserling, H. L., Munoz, F. M., Winokur, P. L., Turley, C. B., Rupp, R. E., Hill, H., Wolff, M., Noah, D. L., Ross, A. C., Cress, G., and Belshe, R. B., Safety and Immune Responses in Children After Concurrent or Sequential 2009 H1N1 and 2009-2010 Seasonal Trivalent Influenza Vaccinations, J Infect Dis, vol. 206, pp. 828-837, 2012.
R. B. Belshe, Stevens, C., Gorse, G. J., Buchbinder, S., Weinhold, K., Sheppard, H., Stablein, D., Self, S., McNamara, J., Frey, S., Flores, J., Excler, J. L., Klein, M., Habib, R. E., Duliege, A. M., Harro, C., Corey, L., Keefer, M., Mulligan, M., Wright, P., Celum, C., Judson, F., and , Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers, J Infec Dis, vol. 183, pp. 1343-52, 2001.
F. K. Newman, Frey, S. E., Blevins, T. P., Yan, L., and Belshe, R. B., Stability of Undiluted and Diluted Vaccinia-Virus Vaccine, Dryvax, J Infectious Diseases, vol. 187, pp. 1319-1322, 2003.